肝细胞癌的肝动脉灌注化疗：临床进展
Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements.
作者信息
Xu Wei, Li Qing, Liang Bin
机构信息
Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Hubei Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan 430022, China.
Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
出版信息
Curr Oncol. 2025 May 28;32(6):313. doi: 10.3390/curroncol32060313.
Intermediate- and advanced-stage hepatocellular carcinoma (HCC) continues to present significant therapeutic challenges. Hepatic artery infusion chemotherapy (HAIC), a well-established locoregional treatment for unresectable HCC, has recently demonstrated promising clinical outcomes both as monotherapy and in combination with systemic therapies. This comprehensive review examines recent clinical advances in HAIC for HCC, with particular emphasis on evolving treatment regimens and their therapeutic efficacy.
中晚期肝细胞癌（HCC）仍然面临重大的治疗挑战。肝动脉灌注化疗（HAIC）是一种针对不可切除HCC的成熟局部区域治疗方法，最近无论是作为单一疗法还是与全身疗法联合使用，都显示出了有前景的临床疗效。这篇综述探讨了HAIC治疗HCC的最新临床进展，特别强调了不断演变的治疗方案及其疗效。
Zotero 插件